Merger Notification - Announcement according to § 10 Cartel Act
Recipharm Group; Vibalogics Holdings LLC
BWB/Z-5887
On 28.02.2022 the Austrian Federal Competition Authority was notified of the following merger:
Planned purchase process
Recipharm AB (Sweden) intends to indirectly, through Recipharm Verwaltungs GmbH (Germany) and Recipharm (Americas) Inc., (United States), acquire sole control over
Vibalogics Holdings LLC (United States) and its subsidiaries. The proposed concentration concerns drug development and manufacturing services.
Affected industry: Manufacture of basic pharmaceutical products and pharmaceutical preparations
Industry sector: C - Verarbeitendes Gewerbe/Herstellung von Waren
Deadline for bringing in an application pursuant to § 11(1) Cartel Act will end on 28.03.2022.
Entrepreneurs whose legal or economic interests are affected by the merger can bring in a written statement at the Federal Competition Authority or the Federal Cartel Prosecutor within 14 days from publication date.
Note: The intervening party has no right to a certain treatment of the statement and will not gain a party position.
Non-prohibition of the merger
The Federal Competition Authority and the Federal Cartel Prosecutor have not applied for examination of the merger by the Cartel Court. The standstill obligation (§ 17 (1) Cartel Act) ends with effect from 29.03.2022 .